Xylazine, heroin and drug markets with Caroline Copeland
Addiction Audio9 Apr 2024

Xylazine, heroin and drug markets with Caroline Copeland

In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entered the US drug market but has been increasingly identified in Europe and the UK, even being identified in vapes sold as containing tetrahydrocannabinol (THC). Caroline covers the harms from xylazine and the implications for public health practitioners before relating the UK issues to wider global drug markets.


"The other really nasty thing that xylazine does is that it can cause blood vessels to contract, and our tissues need blood.....to survive, and if we're closing off those blood vessels, that tissue is going to die and it's going to turn into sores on your skin. And if they get infected it can lead to amputation"


Dr Caroline Copeland is a senior lecturer in pharmacology and toxicology at King’s College London and the director of the National Programme on Substance Use Mortality.


Original article: Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies, triangulating from toxicology, drug testing and law enforcement by Caroline Copeland and colleagues. Published in Addiction (2024)


The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(147)

Brain reward responses in young people with cannabis use disorder with Martine Skumlien and Valentina Lorenzetti

Brain reward responses in young people with cannabis use disorder with Martine Skumlien and Valentina Lorenzetti

In this episode, Dr Tsen Vei Lim talks to Dr Martine Skumlien and Professor Valentina Lorenzetti. Martine is a research fellow at King’s College London in the UK and Valentina is a professor at the Au...

25 Sep 23min

Artificial intelligence in addiction medicine with Patrick Kelly

Artificial intelligence in addiction medicine with Patrick Kelly

In this episode, Dr Elle Wadsworth talks to Patrick Kelly, a doctoral candidate at Brown University School of Public Health in the US. The interview covers Patrick’s article on clinicians' and people ...

18 Sep 20min

The effectiveness of breathing interventions for people who use drugs with Ari Roxburgh

The effectiveness of breathing interventions for people who use drugs with Ari Roxburgh

In this episode, Dr Tsen Vei Lim talks to Dr Ariel (Ari) Roxburgh. Ari is a Clinical Psychologist and addiction researcher at Monash University and Turning Point, Australia. The interview covers Ari’s...

11 Sep 18min

Cannabis, cognition, and the role of nicotine with Emese Kroon

Cannabis, cognition, and the role of nicotine with Emese Kroon

In this episode, Dr Tsen Vei Lim talks to Dr Emese Kroon. Emese is a postdoctoral researcher at the Center for Substance Use and Addiction Research at the Erasmus University Rotterdam in the Netherlan...

4 Sep 20min

What young people see online about illicit vaping with Eleanor Bray

What young people see online about illicit vaping with Eleanor Bray

In this episode, Dr Annika Theodoulou speaks to Eleanor Bray, a research associate at the University of East Anglia, UK. The interview covers Eleanor’s research article covering a content analysis of ...

28 Aug 18min

Redefining success in cannabis use disorder treatment with Toby Atkin

Redefining success in cannabis use disorder treatment with Toby Atkin

In this episode, Dr Elle Wadsworth talks to Dr Tobias (Toby) Atkin, psychiatrist and a research fellow in Addiction Psychiatry at Columbia University in the US. The interview covers Toby’s opinion and...

21 Aug 17min

What we know about alcohol risk in 2026 with Sinclair Carr and Jürgen Rehm

What we know about alcohol risk in 2026 with Sinclair Carr and Jürgen Rehm

In this episode, Dr Tsen Vei Lim talks to Sinclair Carr and Dr Jürgen Rehm. Sinclair is a PhD candidate at the Harvard T.H. Chan School of Public Health in the US, and Jürgen is a Senior Scientist at ...

14 Aug 26min

School-aged outcomes after prenatal opioid exposure with Louise Marryat

School-aged outcomes after prenatal opioid exposure with Louise Marryat

In this episode, Dr Elle Wadsworth talks to Dr Louise Marryat, a senior research fellow at the University of Glasgow, Scotland. The interview covers Louise’s systematic review on prenatal opioid expos...

7 Aug 18min

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
rss-mottagningen
allt-du-velat-veta
angestpodden
rss-ronden
ufo-sverige
det-morka-psyket
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
sexet
bildningskomplexet
rss-ai-med-jonas-benjamin
vetenskap-och-halsa
rss-vetenskapsradion-2
bildningspodden
4health-med-anna-sparre
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
rss-vetenskapsradion
ufo-sverige-2